Compare Cassava Sciences Inc (FLNA) vs Riot Platforms Inc (RIOT) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cassava Sciences Inc vs Riot Platforms Inc — how do they compare? Cassava Sciences Inc trades at $1.1 (market cap $53.14M), while Riot Platforms Inc trades at $18.72 (market cap $7.60B). The key difference: Riot Platforms Inc is far larger — about 143× Cassava Sciences Inc's market cap, and Riot Platforms Inc is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| FLNA | RIOT | |
|---|---|---|
Market Cap | $53.14M | $7.60B |
Sector | Health | Technology |
52-Week High | $4.64 | $28.67 |
52-Week Low | $1.09 | $11.03 |
Enterprise Value | -$33.43M | $8.27B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FLNA trades at $1.06, down 2.75% today, with a bearish technical signal from moving averages but neutral oscillators. The stock shows a low P/B of 0.78, yet profitability metrics are negative, including a -79.59% ROE and -$90.97M net income for 2025. Recent Q1 2026 earnings beat expectations, and analyst consensus is 66.7% buy. News highlights Q1 financial results and a scientific presentation on TSC-related epilepsy therapies.
Outlook remains speculative due to persistent losses and negative cash flows, offset by strong analyst support and recent earnings beats. Key risks include funding needs for drug development and competitive pressures, while potential upside hinges on clinical progress in TSC-related epilepsy treatments.
RIOT trades at $18.46, down 8.57% in the last 24 hours, reflecting bearish technical signals and recent earnings misses. The stock shows a negative net income margin of -132.76% for 2025, with revenue of $647.44M, though it maintains a gross profit margin of 32.35%. Analyst consensus remains strongly bullish with a $27.86 price target, but operational cash flow is negative at -$572.93M, indicating financial strain amid expansion efforts.
Outlook is mixed: high analyst optimism contrasts with fundamental weaknesses and technical bearishness. Opportunities include potential upside from strategic pivots to data centers, but risks involve persistent losses, competitive pressures, and reliance on Bitcoin market conditions. Investors should weigh strong Wall Street support against operational challenges and volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cassava Sciences Inc
Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →About Riot Platforms Inc
Riot Platforms, Inc. is a Bitcoin mining company that focuses on building, operating, and expanding large-scale infrastructure for digital asset mining in North America. The company's operations include Bitcoin mining, data center hosting, and engineering solutions. Riot's strategy emphasizes vertical integration to maximize efficiency and scale its mining capacity, aiming to be a leader in the global Bitcoin and digital infrastructure industry.
Read more on RIOT →
